Nonclinical and Translational Development/Early Phase Clinical Development
Day & Time:
June 24, 11:00AM - 12:30PM
Barry Mangum, MD
Director, Clinical Pharmacology
Duke University Medical Center, United States
This symposium will examine innovations in drug development in China and Latin America as well as the impact of regional cooperation on global development in the Asia Pacific region.
Discuss China regulatory guidelines for a first-in-human study; Describe the regulatory framework of translational researches in the Asia Pacific region; Discuss how early development of new drugs is being conducted in Latin America.
Presentation(s) & Speaker(s):
Would China Be Ready for First-in-human Study in Global R&D Strategy?
Jack Xu, MD,MBA,MS
Senior Vice President
Shanghai Clinical Research Center (SCRC), China
Impacts to Global Development from Paradigm Shifts of Regional Cooperation of Translational Researches in the Asia Pacific Region
Chih-Hwa Wallace Lin, PhD
Director, Division of Resource Development
Center for Drug Evaluation, Taiwan
Early Development of New Drugs in Latin America
João Massud Filho, MD
Brazilian Society of Pharmaceutical Medicine (SBMF), Brazil